| Product Code: ETC100298 | Publication Date: Jun 2021 | Updated Date: Nov 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
In the Hungary human insulin market, the import trend experienced a notable decline from 2023 to 2024, with a growth rate of -40.99%. The compound annual growth rate (CAGR) for imports over the period of 2020 to 2024 stood at -6.82%. This substantial decrease in import momentum could be attributed to shifting demand dynamics or changes in trade policies impacting market stability.
The human insulin market in Hungary provides recombinant insulin formulations for managing diabetes mellitus and regulating blood glucose levels in patients. Human insulin products include rapid-acting, short-acting, intermediate-acting, and long-acting formulations delivered via injections or insulin pumps to control glycemic levels and prevent complications associated with diabetes. This market serves healthcare providers, pharmacies, and patients seeking effective and affordable insulin therapies. It is driven by factors such as diabetes prevalence, aging population, and advancements in insulin delivery devices and formulations.
The Hungary human insulin market is driven by factors such as diabetes prevalence, healthcare access, and advancements in diabetes management. Human insulin, a vital medication for diabetes treatment, regulates blood sugar levels and prevents complications in individuals with diabetes mellitus. Moreover, innovations in insulin formulations, delivery devices, and patient education further stimulate market growth by improving treatment adherence, safety, and efficacy for diabetic patients in Hungary healthcare system.
In the Hungary human insulin market, challenges include ensuring affordability, improving access to treatment, and addressing diabetes management disparities. Healthcare providers must prioritize patient education, promote preventive care measures, and advocate for equitable access to insulin therapy to mitigate the burden of diabetes.
Hungary government supports policies aimed at promoting access to affordable and high-quality human insulin products to ensure the well-being and health of individuals with diabetes. These policies may include promoting competition and transparency in the insulin market to reduce prices and improve access, fostering collaboration between healthcare providers and manufacturers to address supply chain challenges and ensure product availability, and providing subsidies or reimbursement schemes to make insulin therapy more affordable for patients. Additionally, the government may support initiatives to promote diabetes prevention, education, and management to reduce the burden of diabetes in Hungary. By promoting access to human insulin, the government aims to improve health outcomes, reduce healthcare costs, and enhance quality of life for individuals with diabetes in Hungary.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hungary Human Insulin Market Overview |
3.1 Hungary Country Macro Economic Indicators |
3.2 Hungary Human Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Hungary Human Insulin Market - Industry Life Cycle |
3.4 Hungary Human Insulin Market - Porter's Five Forces |
3.5 Hungary Human Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Hungary Human Insulin Market Revenues & Volume Share, By Diabetes Type, 2021 & 2031F |
3.7 Hungary Human Insulin Market Revenues & Volume Share, By Delivery Devices, 2021 & 2031F |
3.8 Hungary Human Insulin Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Hungary Human Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Hungary Human Insulin Market Trends |
6 Hungary Human Insulin Market, By Types |
6.1 Hungary Human Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Hungary Human Insulin Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Hungary Human Insulin Market Revenues & Volume, By Analogue Insulin, 2021-2031F |
6.1.4 Hungary Human Insulin Market Revenues & Volume, By Traditional Human Insulin, 2021-2031F |
6.2 Hungary Human Insulin Market, By Diabetes Type |
6.2.1 Overview and Analysis |
6.2.2 Hungary Human Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021-2031F |
6.2.3 Hungary Human Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021-2031F |
6.2.4 Hungary Human Insulin Market Revenues & Volume, By Gestational Diabetes, 2021-2031F |
6.2.5 Hungary Human Insulin Market Revenues & Volume, By Prediabetes, 2021-2031F |
6.3 Hungary Human Insulin Market, By Delivery Devices |
6.3.1 Overview and Analysis |
6.3.2 Hungary Human Insulin Market Revenues & Volume, By Syringes, 2021-2031F |
6.3.3 Hungary Human Insulin Market Revenues & Volume, By Pens, 2021-2031F |
6.3.4 Hungary Human Insulin Market Revenues & Volume, By Pumps, 2021-2031F |
6.3.5 Hungary Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
6.4 Hungary Human Insulin Market, By End-users |
6.4.1 Overview and Analysis |
6.4.2 Hungary Human Insulin Market Revenues & Volume, By Home Healthcare, 2021-2031F |
6.4.3 Hungary Human Insulin Market Revenues & Volume, By Hospitals, 2021-2031F |
6.4.4 Hungary Human Insulin Market Revenues & Volume, By Over The Counter (OTC), 2021-2031F |
6.4.5 Hungary Human Insulin Market Revenues & Volume, By Clinics, 2021-2031F |
6.4.6 Hungary Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
7 Hungary Human Insulin Market Import-Export Trade Statistics |
7.1 Hungary Human Insulin Market Export to Major Countries |
7.2 Hungary Human Insulin Market Imports from Major Countries |
8 Hungary Human Insulin Market Key Performance Indicators |
9 Hungary Human Insulin Market - Opportunity Assessment |
9.1 Hungary Human Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Hungary Human Insulin Market Opportunity Assessment, By Diabetes Type, 2021 & 2031F |
9.3 Hungary Human Insulin Market Opportunity Assessment, By Delivery Devices, 2021 & 2031F |
9.4 Hungary Human Insulin Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Hungary Human Insulin Market - Competitive Landscape |
10.1 Hungary Human Insulin Market Revenue Share, By Companies, 2024 |
10.2 Hungary Human Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |